Correlation Between Centessa Pharmaceuticals and Grace Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Grace Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Grace Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Grace Therapeutics,, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Grace Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Grace Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Grace Therapeutics,.

Diversification Opportunities for Centessa Pharmaceuticals and Grace Therapeutics,

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Centessa and Grace is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Grace Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grace Therapeutics, and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Grace Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grace Therapeutics, has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Grace Therapeutics, go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Grace Therapeutics,

Given the investment horizon of 90 days Centessa Pharmaceuticals is expected to generate 12.09 times less return on investment than Grace Therapeutics,. But when comparing it to its historical volatility, Centessa Pharmaceuticals PLC is 1.34 times less risky than Grace Therapeutics,. It trades about 0.03 of its potential returns per unit of risk. Grace Therapeutics, is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  305.00  in Grace Therapeutics, on September 12, 2024 and sell it today you would earn a total of  108.00  from holding Grace Therapeutics, or generate 35.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  Grace Therapeutics,

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
Grace Therapeutics, 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Grace Therapeutics, are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile fundamental indicators, Grace Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Centessa Pharmaceuticals and Grace Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and Grace Therapeutics,

The main advantage of trading using opposite Centessa Pharmaceuticals and Grace Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Grace Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grace Therapeutics, will offset losses from the drop in Grace Therapeutics,'s long position.
The idea behind Centessa Pharmaceuticals PLC and Grace Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities